Pharmaceuticals, Biotechnology and Life Sciences
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/CancerTherapeutics?src=hash" target="_blank"gt;#CancerTherapeuticslt;/agt;–The global throat cancer therapeutics market is expected to post a CAGR of close to 7% during…
DUBLIN–(BUSINESS WIRE)–The “Global Eye Allergy Therapeutics Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. This is expected to propel…
DUBLIN–(BUSINESS WIRE)–The “Global Attention deficit Hyperactivity Disorder (ADHD) Drugs Market 2019-2023” report has been added to ResearchAndMarkets.com’s offering. The attention…
JERUSALEM–(BUSINESS WIRE)–Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) today announced the launch of a generic version of Ranexa®1 (ranolazine)…
Approval marks the first chemotherapy-free combination regimen for patients who have relapsed or did not respond to previous treatment Approval…
– Confirmation of VALBIOTIS’s capacity to produce VALEDIA® in compliance with North American and European industrial standards. – A key…
LONDON–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/Analytics?src=hash" target="_blank"gt;#Analyticslt;/agt;–A global data analytics and advisory firm, Quantzig, that delivers actionable analytics solutions to resolve complex business…
DUBLIN–(BUSINESS WIRE)–The “Pharmaceutical Label Market Report: Trends, Forecast and Competitive Analysis” report has been added to ResearchAndMarkets.com’s offering. The global…
DANVILLE, Calif.–(BUSINESS WIRE)–BryoLogyx Inc., (www.BryoLogyx.com), a privately-held, pre-clinical company developing a new class of proprietary drugs to enhance the response…
AMSTERDAM–(BUSINESS WIRE)–Synaffix B.V., a Dutch biotechnology company focused on the advancement of its clinical-stage antibody-drug conjugate (ADC) technology for the…